[HTML][HTML] Genomic classifiers in personalized prostate cancer radiation therapy approaches: a systematic review and future perspectives based on international …
Current risk-stratification systems for prostate cancer (PCa) do not sufficiently reflect the
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International …
SKB Spohn, C Draulans, AU Kishan… - … journal of radiation …, 2022 - scholarship.miami.edu
Current risk-stratification systems for prostate cancer (PCa) do not sufficiently reflect the
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
[PDF][PDF] Genomic classifiers in personalized prostate cancer radiotherapy approaches–a systematic review and future perspectives based on international consensus
SKB Spohn, C Draulans, AU Kishan, MD Daniel Spratt… - researchgate.net
Improvements in screening and diagnostics have led to an increased number of patients
diagnosed with all stages of PCa [2, 3]. Radiotherapy (RT) plays a central role in the …
diagnosed with all stages of PCa [2, 3]. Radiotherapy (RT) plays a central role in the …
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International …
SKB Spohn, C Draulans, AU Kishan, D Spratt, A Ross… - 2023 - mediatum.ub.tum.de
Current risk-stratification systems for prostate cancer (PCa) do not sufficiently reflect the
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
[PDF][PDF] Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International …
SKB Spohn, C Draulans, AU Kishan, D Spratt, A Ross… - 2023 - repository.ubn.ru.nl
Current risk-stratification systems for prostate cancer (PCa) do not sufficiently reflect the
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International …
SKB Spohn, C Draulans, AU Kishan… - … Journal of Radiation …, 2023 - pure.johnshopkins.edu
Current risk-stratification systems for prostate cancer (PCa) do not sufficiently reflect the
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International …
SKB Spohn, C Draulans, AU Kishan… - International Journal of …, 2023 - hal.science
Current risk-stratification systems for prostate cancer (PCa) do not sufficiently reflect the
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
[引用][C] Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International …
SKB Spohn, C Draulans, AU Kishan, D Spratt, A Ross… - 2023 - oparu.uni-ulm.de
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International …
SKB Spohn, C Draulans, AU Kishan… - … Journal of Radiation …, 2023 - jhu.pure.elsevier.com
Current risk-stratification systems for prostate cancer (PCa) do not sufficiently reflect the
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International …
SKB Spohn, C Draulans, AU Kishan… - … journal of radiation …, 2023 - pubmed.ncbi.nlm.nih.gov
Current risk-stratification systems for prostate cancer (PCa) do not sufficiently reflect the
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …
disease heterogeneity. Genomic classifiers (GC) enable improved risk stratification after …